Optimizing the care of patients with advanced prostate cancer in the UK: current challenges and future opportunities-Reference-Cited by-同舟云学术

Optimizing the care of patients with advanced prostate cancer in the UK: current challenges and future opportunities

Published:2012-03-19 Issue:5 Volume:110 Page:658-667
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:

Author:

Payne Heather,Bahl Amit,Mason Malcolm,Troup Janis,De Bono Johann

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2011.10886.x/fullpdf

Reference54 articles.

1. Heidenreich A Bolla M Joniau S et al EAU Guidelines on Prostate Cancer 2010 http://www.uroweb.org/gls/pdf/Prostate%20Cancer%202010%20June%2017th.pdf

2. Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group;Scher;J Clin Oncol,2008

3. Treatment of hormone-refractory prostate cancer with docetaxel or mitoxantrone: relationships between prostate-specific antigen, pain, and quality of life response and survival in the TAX-327 study;Berthold;Clin Cancer Res,2008

4. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer;Tannock;N Engl J Med,2004

5. N.I.C.E. Prostate Cancer: Diagnosis and Treatment 2008 http://www.nice.org.uk/nicemedia/pdf/CG58NICEGuideline.pdf

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic Development of Solid Lipid Nanoparticles of Abiraterone Acetate with Improved Oral Bioavailability and Anticancer Activity for Prostate Carcinoma Treatment;ACS Omega;2022-05-10

2. Signs and symptoms in relation to progression, experiences of an uncertain illness situation in men with metastatic castration‐resistant prostate cancer—A qualitative study;European Journal of Cancer Care;2022-04-12

3. Understanding how prostate cancer patients value the current treatment options for metastatic castration resistant prostate cancer;Urologic Oncology: Seminars and Original Investigations;2018-05

4. Managing patients with metastatic prostate cancer: who takes the lead?;Trends in Urology & Men's Health;2017-07

5. Sintokamide A Is a Novel Antagonist of Androgen Receptor That Uniquely Binds Activation Function-1 in Its Amino-terminal Domain;Journal of Biological Chemistry;2016-10